This webinar will enable you to better characterize the maximum tolerated dose to improve your probability of success in later trials.
At the end of the webinar you will be able to:
- Simulate and analyse Phase 1 dose escalation trials for determining maximum tolerated dose (MTD)
- Understand a range of different methodologies that are used in Phase 1 dose escalation trials
- Communicate findings to the clinical team using East’s intuitive graphs and tables
- Simulate a dose escalation design followed by single-arm cohort expansion
Presenter:
- Pantelis Vlachos, Principal, Strategic Consulting, Cytel
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.